TOXR gets green light – All about 21Shares’ low-fee XRP ETF

After years of getting caught up in regulatory uncertainty, Ripple [XRP] has officially cemented its place in the U.S. institutional market.

21Shares XRP ETF gets greenlight

Amidst various XRP ETF approvals, the CBOE BZX Exchange has also approved the listing of the 21Shares XRP ETF (TOXR).

This latest green light brings the total number of U.S. spot XRP-related funds to five, intensifying the pressure on established players like Canary Capital, Bitwise, Grayscale, and Franklin Templeton.

And, now with the total capital funneling into these regulated XRP products accelerating toward $1 billion mark.

With this milestone approaching, the conversation shifts. It is no longer about whether XRP has a place on Wall Street. Instead, the focus turns to how quickly institutional capital can reshape its liquidity and price dynamics.

Why 21Shares XRP ETF a good competitor?

That being said, 21Shares enters the fray with a significant competitive advantage, offering a low annual sponsor fee of just 0.3%.

The firm charges this fee daily and pays it weekly in XRP, using this aggressive pricing strategy to capture market share quickly.

When compared to the average fees of existing crypto ETPs, 21Shares’ pricing signals that issuers expect the battle for asset gathering to play out primarily on cost.

Additionally, the fund tracks the CME CF XRP‑Dollar Reference Rate, New York Variant. 

This gives investors professional‑grade exposure to XRP’s price performance without the need to manage token custody themselves.

Meanwhile, 21Shares enhances its appeal by placing strong emphasis on security and compliance. It also deploys a robust system that relies on multiple custodians, a key differentiator designed to meet the needs of institutional clients.

Regulatory and technical horizon

The CBOE has approved the listing. However, the fund’s S‑1 registration still carries a “delaying amendment.”

This procedural hurdle suggests the issuer may be waiting for the final CERT notice (Comprehensive Exchange‑Traded Receipts notice) or direct SEC approval.

Only once these steps are completed can the fund move forward with its official launch. This final step is largely procedural, given the CBOE listing approval and 21Shares’ fifth update to its S-1 earlier this week.

Now, as trading desks await the official launch, the immediate market reaction saw XRP trading at $2.01 following a modest 2.44% drop over the last 24 hours, at press time.

What’s more?

Still, this institutional validation for XRP is undeniable despite XRP’s prices confirming short-term seller strength.

In short, the market is witnessing a technical tug-of-war, wherein a solid foundation of institutional adoption is battling an entrenched bearish price structure.

Thus, while momentum is currently shaky, traders should stay cautious before the larger downtrend returns.

Final Thoughts

• With five U.S. spot ETFs approved for listing, the asset has effectively crossed the threshold from regulatory ambiguity to Wall Street legitimacy.
• XRP’s return to the $2.4 support zone reflects renewed buying interest driven by ETF optimism, yet a recent price drop indicates caution.